Peter C. Cherry

1.0k total citations
23 papers, 824 citations indexed

About

Peter C. Cherry is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Peter C. Cherry has authored 23 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Organic Chemistry and 6 papers in Epidemiology. Recurrent topics in Peter C. Cherry's work include Influenza Virus Research Studies (6 papers), Glycosylation and Glycoproteins Research (5 papers) and Berberine and alkaloids research (3 papers). Peter C. Cherry is often cited by papers focused on Influenza Virus Research Studies (6 papers), Glycosylation and Glycoproteins Research (5 papers) and Berberine and alkaloids research (3 papers). Peter C. Cherry collaborates with scholars based in United Kingdom and Germany. Peter C. Cherry's co-authors include Peter D. Howes, Paul W. Smith, Steven L. Sollis, Richard C. Bethell, Neil R. Taylor, Ian D. Starkey, Andrew R. Whittington, Jan Scicinski, Kevin N. Cobley and J.N. Varghese and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

Peter C. Cherry

22 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter C. Cherry United Kingdom 13 497 345 217 162 79 23 824
Peter D. Howes United Kingdom 17 805 1.6× 358 1.0× 236 1.1× 153 0.9× 83 1.1× 43 1.1k
J. E. MUNROE United States 15 323 0.6× 352 1.0× 167 0.8× 88 0.5× 55 0.7× 26 877
Manohar Saindane United States 20 482 1.0× 237 0.7× 186 0.9× 46 0.3× 20 0.3× 40 1.1k
Peter W. K. Woo United States 16 284 0.6× 451 1.3× 73 0.3× 189 1.2× 18 0.2× 45 781
Åsa Rosenquist Sweden 19 337 0.7× 399 1.2× 205 0.9× 79 0.5× 90 1.1× 42 1.0k
R. D. G. Cooper United States 22 789 1.6× 435 1.3× 64 0.3× 273 1.7× 34 0.4× 44 1.2k
Ashoke Sharon India 24 896 1.8× 492 1.4× 148 0.7× 111 0.7× 15 0.2× 104 1.5k
Mauricio Cabrera Uruguay 17 593 1.2× 257 0.7× 100 0.5× 114 0.7× 112 1.4× 42 959
Hirohiko Sugimoto Japan 15 453 0.9× 403 1.2× 100 0.5× 50 0.3× 10 0.1× 36 1.1k
Gaochan Wu China 20 540 1.1× 389 1.1× 194 0.9× 98 0.6× 40 0.5× 24 1.1k

Countries citing papers authored by Peter C. Cherry

Since Specialization
Citations

This map shows the geographic impact of Peter C. Cherry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Cherry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Cherry more than expected).

Fields of papers citing papers by Peter C. Cherry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Cherry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Cherry. The network helps show where Peter C. Cherry may publish in the future.

Co-authorship network of co-authors of Peter C. Cherry

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Cherry. A scholar is included among the top collaborators of Peter C. Cherry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Cherry. Peter C. Cherry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Butchers, Peter R., Peter C. Cherry, F. Ellis, et al.. (2000). The discovery and synthesis of highly potent, A2a receptor agonists. Bioorganic & Medicinal Chemistry Letters. 10(4). 403–406. 15 indexed citations
2.
Andrews, David, et al.. (1999). Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-Guanidino-Neu5Ac2en (Zanamivir) modified in the glycerol side-chain. European Journal of Medicinal Chemistry. 34(7-8). 563–574. 33 indexed citations
5.
Sollis, Steven L., Paul W. Smith, Peter D. Howes, Peter C. Cherry, & Richard C. Bethell. (1996). Novel inhibitors of influenza sialidase related to GG167 Synthesis of 4-amino and guanidino-4H-pyran-2-carboxylic acid-6-propylamides; selective inhibitors of influenza a virus sialidase. Bioorganic & Medicinal Chemistry Letters. 6(15). 1805–1808. 48 indexed citations
6.
Kitchin, John R., et al.. (1995). Synthesis of Benzodioxinopyrroles as selective α2-adrenoceptor antagonists. Bioorganic & Medicinal Chemistry. 3(12). 1595–1603. 1 indexed citations
7.
Starkey, Ian D., Mahmoud Mahmoudian, David Noble, et al.. (1995). Synthesis and influenza virus sialidase inhibitory activity of the 5-desacetamido analogue of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid (GG167). Tetrahedron Letters. 36(2). 299–302. 22 indexed citations
8.
Procopiou, Panayiotis A., Peter C. Cherry, Martyn J. Deal, & R. B. LAMONT. (1994). A reinvestigation of the synthesis of trans-(±)-1,2,3,4,4a,10a-hexahydro [1,4] benzodioxino[2,3-c]pyridine. Journal of the Chemical Society Perkin Transactions 1. 1773–1777. 3 indexed citations
9.
Pattenden, Gerald, et al.. (1993). Facile synthesis of the “tricarbonyl” subunit in the immunosuppressant rapamycin. Tetrahedron Letters. 34(16). 2677–2680. 15 indexed citations
10.
Gardner, C., D.J. Twissell, Peter Charlton, & Peter C. Cherry. (1991). Acute and chronic effects of renin inhibitor GR70982 in the conscious marmoset. European Journal of Pharmacology. 192(3). 329–335. 5 indexed citations
11.
Cherry, Peter C., et al.. (1980). Conversion of clavulanic acid into thiadeoxa nuclear analogues. Tetrahedron Letters. 21(6). 561–564. 7 indexed citations
12.
Cherry, Peter C., et al.. (1978). Reactions of sulphur nucleophiles with activated derivatives of clavulanic acid. Journal of the Chemical Society Chemical Communications. 467–467. 6 indexed citations
13.
Cherry, Peter C., et al.. (1978). Preparation of the 7-oxo-4-oxa-1-azabicyclo[3.2.0]hept-2-ene system and the reversible cleavage of its oxazoline ring. Journal of the Chemical Society Chemical Communications. 469–469. 25 indexed citations
14.
Scott, A. Ian, Peter C. Cherry, & Chunhua Wei. (1974). Regio- and stereospecific models for the biosynthesis of the indole alkaloids—III. Tetrahedron. 30(17). 3013–3019. 10 indexed citations
15.
Cherry, Peter C., John Evans, Ewart R. H. Jones, et al.. (1970). Microbiological hydroxylation of steroids. Part I. Proton magnetic resonance spectra of ketones, alcohols, and acetates in the androstane, pregnane, and œstrane series. Journal of the Chemical Society C Organic. 0(2). 250–257. 70 indexed citations
16.
Cherry, Peter C., et al.. (1969). Mechanism of indole alkaloid biosynthesis. The Corynanthe-Strychnos relationship. Journal of the American Chemical Society. 91(17). 4932–4933. 27 indexed citations
17.
Cherry, Peter C., et al.. (1969). Biogenetic-type chemistry of the indole alkaloids. Journal of the American Chemical Society. 91(21). 5872–5874. 12 indexed citations
18.
Cherry, Peter C., et al.. (1968). Intramolecular bonding and relative stabilities of syn- and anti-α-hydroximino-ketones. Journal of the Chemical Society C Organic. 0(0). 459–460. 2 indexed citations
19.
Aplin, Robin T. & Peter C. Cherry. (1966). Configurational effects in the mass spectra of steroidal polyketones. Chemical Communications (London). 628–628. 2 indexed citations
20.
Cherry, Peter C., Ewart R. H. Jones, & G. D. Meakins. (1966). Microbiological hydroxylation at position 3 of androst-5-en-7-one. Chemical Communications (London). 587–587. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026